Tagged immuno-oncology

Press Release

Aptevo Therapeutics Announces Exercise of Warrants for $6.2 Million Gross Proceeds

 Read More
ScaiPod: Revolutionizing Immuno-Oncology With Multi-Omics and AI at Scale
Press Release

ScaiPod: Revolutionizing Immuno-Oncology With Multi-Omics and AI at Scale

 Read More
BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies
Press Release

BioMed X and Merck Expand Collaboration Aiming to Leverage Cancer-Specific Vulnerabilities for Targeted Therapies

 After successfully completing a project in RNA splicing in cancer this January, BioMed X and Merck continue their oncology collaboration to explore tumor immunogenicity enhancers. Read More
Press Release

Elixiron Immunotherapeutics Announces Closing of $27 Million Series A-1 Financing Round to Progress Alzheimer's Disease and Vitiligo Clinical-Stage Assets

 Read More
John Poulos Appointed to Memgen's Board of Directors
Press Release

John Poulos Appointed to Memgen's Board of Directors

 Read More
Memgen Announces Research to Be Presented at 2020 American Association of Cancer Research (AACR) Meeting
Press Release

Memgen Announces Research to Be Presented at 2020 American Association of Cancer Research (AACR) Meeting

 Read More
Memgen Announces Exclusive License Agreements With Moffitt Cancer Center to Develop Innovative Cancer Immunotherapies
Press Release

Memgen Announces Exclusive License Agreements With Moffitt Cancer Center to Develop Innovative Cancer Immunotherapies

 Agreements Cement Strong Collaboration with Premier Cancer Center Read More
Memgen Announces Addition to Board of Directors
Press Release

Memgen Announces Addition to Board of Directors

 Christopher Pagano Appointed Independent Director Read More
Press Release

Memgen Appoints Gregory Brown as Chief Executive Officer

 Company founder Robert Coates becomes Executive Chairman Read More
International Association of Women Recognizes Debra Robinson as a 2018-2019 Influencer
Press Release

International Association of Women Recognizes Debra Robinson as a 2018-2019 Influencer

 Debra Robinson, MBA, MPM, PMP, Sr. Director, Program and Alliance Management at Maverick Therapeutics, joins networking organization Read More
Investigating the Human Immune Response With Myriad RBM's TruCulture® System & NanoString® nCounter® Autoimmune Profiling Panel, New Webinar Hosted by Xtalks
Press Release

Investigating the Human Immune Response With Myriad RBM's TruCulture® System & NanoString® nCounter® Autoimmune Profiling Panel, New Webinar Hosted by Xtalks

 Read More
Advanced Cancer Patients Come From Their Chemo Chairs to Model on the Catwalk
Press Release

Advanced Cancer Patients Come From Their Chemo Chairs to Model on the Catwalk

 Say YES to Hope and SMGlobal Catwalk make dreams come true for stage 4 cancer patients as they model during SMGlobal Dallas Revolution. Read More
Upcoming Xtalks Webinar: A Better Predictive Model for Oncology Drug Development Beyond Traditional Platforms
Press Release

Upcoming Xtalks Webinar: A Better Predictive Model for Oncology Drug Development Beyond Traditional Platforms

 Delineation of the intra-tumor microenvironment in a dynamic, spatiotemporal setting is critical for investigating the activity and efficacy of candidate oncology drugs. The majority of solid cancers contain unorganized, highly complex microenvironments wherein a dysregulated phenotype impacts treatment outcomes at a personalized level. Read More
Press Release

Definiens Embarks on Digital Pathology Collaboration With Merck's Exploratory and Clinical Development Programs

 Read More
Noona Healthcare Locks Leading Academic Partnership to Launch Study on Long-Term Tolerability of Cancer Immuno-Oncology Therapies
Press Release

Noona Healthcare Locks Leading Academic Partnership to Launch Study on Long-Term Tolerability of Cancer Immuno-Oncology Therapies

 Read More
Life Science Leaders Announce Partnership for Pioneering Advanced Therapies Gathering in Miami 2019
Press Release

Life Science Leaders Announce Partnership for Pioneering Advanced Therapies Gathering in Miami 2019

 World Stem Cell Summit and Phacilitate Leaders World to bring FOUR Meetings Together to Create Collaboration Needed to Deliver Global Cell and Gene Therapies! Read More
Releasing the Immune System Brakes: The Importance of Modelling Effects in Non-Clinical Safety Studies, New Webinar Hosted by Xtalks
Press Release

Releasing the Immune System Brakes: The Importance of Modelling Effects in Non-Clinical Safety Studies, New Webinar Hosted by Xtalks

 Read More
ISCT Join as Strategic Partners for Phacilitate Trade Mission to Japan and South Korea
Press Release

ISCT Join as Strategic Partners for Phacilitate Trade Mission to Japan and South Korea

 ISCT confirmed as strategic partner for Phacilitate's trade mission to Asia, June 2018 Read More
HistoGeneX PD-L1 IHC and CD8 Work in ABACUS Trial Presented at ASCO 2018
Press Release

HistoGeneX PD-L1 IHC and CD8 Work in ABACUS Trial Presented at ASCO 2018

 Read More
Overcoming the Challenges of Immuno-Oncology Biomarker Discovery: From Sample to Analytics, New Webinar Hosted by Xtalks
Press Release

Overcoming the Challenges of Immuno-Oncology Biomarker Discovery: From Sample to Analytics, New Webinar Hosted by Xtalks

 Read More
Leveraging Key Biomarkers to Advance Immuno-Oncology Drug Development and Find the Right Trial Participants, New Webinar Hosted by Xtalks
Press Release

Leveraging Key Biomarkers to Advance Immuno-Oncology Drug Development and Find the Right Trial Participants, New Webinar Hosted by Xtalks

 Presented by Covance Chief Scientific Officer Steve Anderson, Ph.D., and Covance Global Leader, Precision Medicine and Head, Biomarker Solution Center, Suso Platero, Ph.D., this webinar will address the spectrum of immunotherapy development considerations and their implications for drug developers. Read More
Press Release

Bell Biosystems, Inc. Announces Pre-Clinical Results of Major in Vivo Safety Study Milestone

 Read More
Press Release

Bell Biosystems, Inc. to Present at the Biotech Showcase™ Annual Conference on January 8, 2018

 Read More
Global Immuno-Oncology Market to Be Worth US$ 27,846.3 Mn by 2025 - Persistence Market Research
Press Release

Global Immuno-Oncology Market to Be Worth US$ 27,846.3 Mn by 2025 - Persistence Market Research

 Global Market Study on Immuno-Oncology: Immune Checkpoint Inhibitors Segment Projected to be the Most Lucrative Segment by Therapy Type Read More
ImmunoBiochem Corporation Announces the Completion of a New Round of Financing and Residency at Johnson & Johnson Innovation, JLABS @ Toronto
Press Release

ImmunoBiochem Corporation Announces the Completion of a New Round of Financing and Residency at Johnson & Johnson Innovation, JLABS @ Toronto

 Read More
New Intelligence Tool Helps Researchers Cope With Immuno-Oncology Boom
Press Release

New Intelligence Tool Helps Researchers Cope With Immuno-Oncology Boom

 Hanson Wade, the London-based life sciences knowledge services specialist, has launched IO Combination Trials Intelligence. Read More
Study Reveals How to Reprogram Cells in Our Immune System
Press Release

Study Reveals How to Reprogram Cells in Our Immune System

 The discovery could improve treatments for autoimmune diseases and cancer Read More
Press Release

ImmunoBiochem Corporation Partners With the Centre for the Commercialization of Antibodies and Biologics at the University of Toronto to Advance New Antibody Drug Conjugates

 Read More